Metabolic disease often begins years before obesity, type 2 diabetes, fatty liver or heart disease is recognized. Here is how the process unfolds, what to measure before standard tests flag it, and why acting early matters.

Only about 12% of American adults are metabolically healthy. That was the finding when researchers at the University of North Carolina analyzed nearly 9,000 adults in the national NHANES survey and asked how many had normal waist size, blood sugar, blood pressure, triglycerides and HDL cholesterol without medication. Even among people at a normal weight, fewer than one in three passed. Looking healthy and being metabolically healthy turned out to be two different things.

A second study explains why. In the British Whitehall II cohort , more than 6,500 adults without diabetes were followed for years, and 505 eventually developed it. Working backward from diagnosis, investigators found that insulin resistance had been building, and pancreatic output drifting, for more than a decade. Hemoglobin A1C, a marker of high blood glucose, is the number most physicians rely on and it rose only in the last few years, the window labeled prediabetes.

That is the pattern I frequently see in clinic. A patient in his fifties arrives because a routine test flagged his liver enzymes. He feels fine. His weight is unremarkable. Yet his imaging shows a fatty liver, and the process that produced it has been running quietly for years. In my forthcoming book, Adaptive (Chapter 4), I describe metabolic disease not as a set of separate diagnoses but as one disease with many faces, building through six cumulative layers. The first five are usually silent. All six are measurable. They are repeated fuel surges, compensatory hyperinsulinemia, visceral and ectopic fat, tissue-specific insulin resistance, loss of metabolic flexibility and, finally, organ decompensation.

Layer 1: Repeated Fuel Surges

The first layer is not just what you eat . It is how your body clears it. After a meal, glucose and fat-carrying particles rise, get routed to tissues and settle back down. The trouble starts when those swings become larger, last longer, and arrive again before the last one has cleared.

The same meal does not produce the same internal exposure in everyone. In the PREDICT 1 study published in Nature Medicine , 1,002 adults ate identical meals, and their post-meal responses varied by roughly 60% for glucose and 100% for triglycerides. Food is the input. Clearance is physiology, and that is where the disease begins.

How to see it: a continuous glucose monitor or a structured meal challenge shows the shape and duration of post-meal excursions that a fasting value cannot.

Layer 2: Compensatory Hyperinsulinemia

The pancreas answers rising fuel pressure by producing more insulin, and for years it succeeds. Two people can share a fasting glucose of 92; one holds it there with little insulin, the other needs several times as much. The glucose reports the outcome. The insulin reveals the cost.

Insulin is also the body’s master storage signal. Held high, it keeps directing the liver to turn surplus into fat, tells the kidneys to hold sodium and nudges blood pressure upward. I have previously written about how insulin and other hormonal signals can also influence the body’s defended weight range . Overfeeding experiments show insulin secretion rises within days, before weight or insulin resistance changes. This layer is not the wreckage of the process. It is the opening move.

How to see it: fasting insulin blood test.

Layer 3: Visceral And Ectopic Fat

Persistent insulin drives storage in one direction only. When the body’s normal fat depots reach capacity, surplus spills into the liver, muscle and pancreas, tissues never designed to hold it. That capacity is what Newcastle diabetologist Roy Taylor calls the personal fat threshold, and it varies widely between people. Roughly one in six people with type 2 diabetes was never heavy at all.

Visceral fat is especially dangerous because much of it drains directly into the liver through the portal vein, delivering fatty acids and inflammatory signals such as IL-6 and TNF-alpha before the rest of the circulation can dilute them. This is why two people with the same body mass index can face very different risk , and why the “thin outside, fat inside” pattern exists.

How to see it: a waist-to-height ratio of 0.5 or greater is a crude indication someone may have increased visceral fat. Body composition imaging including DEXA, which estimates it, and MRI or CT, which quantify liver and visceral fat directly, are also widely available options.

Layer 4: Tissue-Specific Insulin Resistance

Fat that lodges inside liver and muscle cells generates lipid byproducts, chiefly diacylglycerols and ceramides, that interfere with insulin signaling from the inside. Insulin still reaches its receptor. The message that should follow is muffled.

The failure differs by tissue. In muscle, less glucose gets in. In the liver, the organ keeps releasing its own glucose even as a meal arrives, so blood sugar is now being fed from two sources at once, the gut and the liver itself. The pancreas responds with still more insulin, which produces still more liver fat, and the cycle reinforces itself.

How to see it: HOMA-IR, calculated from fasting glucose and insulin, is the simplest test and tracks how hard the system is working to hold a normal reading. When no insulin level is available, a high triglyceride-to-HDL ratio on a standard lipid panel is a rough proxy. For a fuller picture, an oral glucose tolerance test with insulin measured at each time point shows how muscle and liver handle a fuel load and whether the pancreas is still keeping pace.

Layer 5: Loss Of Metabolic Flexibility

A healthy body switches fuels effortlessly, burning mostly carbohydrate after a meal and shifting toward fat as the hours pass and the fasted state sets in. By this stage, the switch is stuck. The body runs in a fed-state pattern hours after eating and cannot turn cleanly to stored fat, even though the stores are overfull.

This is not a curiosity. In NIH studies using whole-room calorimetry, adults who failed to increase fat burning when dietary fat was abundant gained more weight over the following year, and earlier work in Pima Indians found the least flexible individuals had roughly two and a half times the risk of significant weight gain. Inflexibility sits on top of insulin resistance and pushes more energy back into storage.

How to see it: the respiratory exchange ratio measured by indirect calorimetry across fasting, feeding and exercise. A single reading is a snapshot; the change between states is what matters.

Layer 6: Organ Decompensation

Eventually an organ runs out of room to compensate, and disease finally gets a name. This is where you see that abnormal hemoglobin A1C. In an autopsy series of 124 human pancreases, beta-cell volume was already about 40% lower in people with impaired fasting glucose and 63% lower in those with type 2 diabetes. In a cohort of more than 32,000 people with fatty liver, higher insulin resistance predicted progression to fibrosis. Across 65 prospective studies covering more than half a million adults, high HOMA-IR was associated with a 64% greater risk of coronary heart disease, years before any diabetes diagnosis. Which organ gives way first depends on genetics, fat distribution, muscle mass and the specific pressures a person carries.

Timing matters because the damage is not equally reversible at every stage. When the same Newcastle group put people with type 2 diabetes through an identical weight-loss program, those diagnosed within the previous four years typically recovered pancreatic function; those a decade in usually did not. And in the landmark UKPDS trial , tight glucose control begun at diagnosis reduced heart attacks and deaths well after the study ended, a benefit that later trials starting treatment further down the road could not reproduce. The biology is more forgiving early. Waiting for an abnormal A1C means waiting until part of that window has already closed.

The hepatologist sees fatty liver. The cardiologist sees coronary disease. The endocrinologist sees diabetes. The bariatric specialist sees patients with obesity. But most patients do not have four totally separate diseases. They have one underlying condition, surfacing wherever their biology gave way first, after years of silent compensation that standard labs were never designed to catch.

The practical shift is simple. Do not wait for the glucose cliff. Ask for fasting insulin alongside glucose, calculate HOMA-IR, and pay attention to liver enzymes, triglycerides and waist size even when weight looks fine. If those point in the wrong direction, body composition imaging and a metabolic flexibility test can show how far the process has advanced. Each layer leaves a footprint. In most cases we are not lacking the tools to find it. We are simply not looking.

I explore these six layers of metabolic disease, the upstream drivers that set them in motion, and what can reverse them in Adaptive and in a companion episode of the EverHuman Podcast .